vs
Ouster, Inc.（OUST）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Ouster, Inc.的1.1倍（$69.8M vs $62.2M），Ouster, Inc.同比增速更快（106.6% vs 21.2%），过去两年Ouster, Inc.的营收复合增速更高（54.8% vs 53.7%）
Ouster, Inc.是总部位于美国加利福尼亚州旧金山的激光雷达技术企业，主打高分辨率数字化3D激光雷达传感器，产品广泛应用于自动驾驶车辆、工业自动化、机器人、无人机、地图测绘、国防及安防等领域。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
OUST vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.1倍
$62.2M
营收增速更快
OUST
高出85.4%
21.2%
两年增速更快
OUST
近两年复合增速
53.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.2M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | 60.2% | 91.5% |
| 营业利润率 | 1.5% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | 106.6% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $0.10 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OUSTRIGL
| Q4 25 | $62.2M | $69.8M | ||
| Q3 25 | $39.5M | $69.5M | ||
| Q2 25 | $35.0M | $101.7M | ||
| Q1 25 | $32.6M | $53.3M | ||
| Q4 24 | $30.1M | $57.6M | ||
| Q3 24 | $28.1M | $55.3M | ||
| Q2 24 | $27.0M | $36.8M | ||
| Q1 24 | $25.9M | $29.5M |
净利润OUSTRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $-21.7M | $27.9M | ||
| Q2 25 | $-20.6M | $59.6M | ||
| Q1 25 | $-22.0M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $-25.6M | $12.4M | ||
| Q2 24 | $-23.9M | $-1.0M | ||
| Q1 24 | $-23.8M | $-8.2M |
毛利率OUSTRIGL
| Q4 25 | 60.2% | 91.5% | ||
| Q3 25 | 42.1% | 93.2% | ||
| Q2 25 | 45.2% | 95.6% | ||
| Q1 25 | 41.3% | 91.7% | ||
| Q4 24 | 43.8% | 89.9% | ||
| Q3 24 | 38.3% | 85.5% | ||
| Q2 24 | 33.7% | 92.4% | ||
| Q1 24 | 28.6% | 93.1% |
营业利润率OUSTRIGL
| Q4 25 | 1.5% | 33.2% | ||
| Q3 25 | -61.4% | 40.9% | ||
| Q2 25 | -76.5% | 60.1% | ||
| Q1 25 | -73.0% | 23.9% | ||
| Q4 24 | -85.1% | 28.9% | ||
| Q3 24 | -98.0% | 25.4% | ||
| Q2 24 | -93.6% | 1.2% | ||
| Q1 24 | -99.5% | -23.6% |
净利率OUSTRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | -55.0% | 40.2% | ||
| Q2 25 | -58.8% | 58.6% | ||
| Q1 25 | -67.5% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | -91.1% | 22.5% | ||
| Q2 24 | -88.4% | -2.8% | ||
| Q1 24 | -91.9% | -27.9% |
每股收益（稀释后）OUSTRIGL
| Q4 25 | $0.10 | $14.11 | ||
| Q3 25 | $-0.37 | $1.46 | ||
| Q2 25 | $-0.38 | $3.28 | ||
| Q1 25 | $-0.42 | $0.63 | ||
| Q4 24 | $-0.46 | $0.82 | ||
| Q3 24 | $-0.54 | $0.70 | ||
| Q2 24 | $-0.53 | $-0.06 | ||
| Q1 24 | $-0.55 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $208.6M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $261.7M | $391.5M |
| 总资产 | $349.5M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资OUSTRIGL
| Q4 25 | $208.6M | $155.0M | ||
| Q3 25 | $244.5M | $137.1M | ||
| Q2 25 | $226.5M | $108.4M | ||
| Q1 25 | $168.2M | $77.1M | ||
| Q4 24 | $172.0M | $77.3M | ||
| Q3 24 | $151.4M | $61.1M | ||
| Q2 24 | $184.2M | $49.1M | ||
| Q1 24 | $187.8M | $49.5M |
总债务OUSTRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益OUSTRIGL
| Q4 25 | $261.7M | $391.5M | ||
| Q3 25 | $247.4M | $117.6M | ||
| Q2 25 | $221.0M | $81.9M | ||
| Q1 25 | $167.9M | $18.6M | ||
| Q4 24 | $180.9M | $3.3M | ||
| Q3 24 | $171.7M | $-14.6M | ||
| Q2 24 | $170.6M | $-29.9M | ||
| Q1 24 | $167.2M | $-31.7M |
总资产OUSTRIGL
| Q4 25 | $349.5M | $513.6M | ||
| Q3 25 | $353.8M | $242.5M | ||
| Q2 25 | $321.8M | $206.7M | ||
| Q1 25 | $268.6M | $176.0M | ||
| Q4 24 | $276.1M | $164.0M | ||
| Q3 24 | $255.2M | $139.4M | ||
| Q2 24 | $309.9M | $128.4M | ||
| Q1 24 | $317.7M | $126.5M |
负债/权益比OUSTRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.4M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-37.2M | — |
| 自由现金流率自由现金流/营收 | -59.8% | — |
| 资本支出强度资本支出/营收 | 35.0% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-64.8M | — |
8季度趋势，按日历期对齐
经营现金流OUSTRIGL
| Q4 25 | $-15.4M | $22.0M | ||
| Q3 25 | $-18.3M | $24.0M | ||
| Q2 25 | $-1.3M | $30.5M | ||
| Q1 25 | $-4.9M | $-893.0K | ||
| Q4 24 | $-2.6M | $14.5M | ||
| Q3 24 | $-3.8M | $21.7M | ||
| Q2 24 | $-21.6M | $302.0K | ||
| Q1 24 | $-5.7M | $-5.0M |
自由现金流OUSTRIGL
| Q4 25 | $-37.2M | — | ||
| Q3 25 | $-20.0M | — | ||
| Q2 25 | $-2.2M | — | ||
| Q1 25 | $-5.4M | — | ||
| Q4 24 | $-4.0M | — | ||
| Q3 24 | $-4.3M | — | ||
| Q2 24 | $-22.0M | — | ||
| Q1 24 | $-7.1M | — |
自由现金流率OUSTRIGL
| Q4 25 | -59.8% | — | ||
| Q3 25 | -50.7% | — | ||
| Q2 25 | -6.3% | — | ||
| Q1 25 | -16.6% | — | ||
| Q4 24 | -13.3% | — | ||
| Q3 24 | -15.4% | — | ||
| Q2 24 | -81.5% | — | ||
| Q1 24 | -27.4% | — |
资本支出强度OUSTRIGL
| Q4 25 | 35.0% | — | ||
| Q3 25 | 4.3% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 4.8% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 5.3% | — |
现金转化率OUSTRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
